Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway
Related Experiment Video
Updated: Aug 19, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Xiaodong Li1, Xuedong Yin1, Heyi Bao2
1Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Backgrounds:
Sorafenib-resistance leads to poor prognosis and high mortality in advanced hepatocellular carcinoma (HCC), and this study aims to investigate the functional role of a circular RNA ITCH (circITCH) in regulating the sorafenib-resistance of HCC and its underlying mechanisms.
Methods:
The expression of circITCH in HCC tissues and cell lines were detected by performing quantitative real-time polymerase chain reaction. Sorafenib-resistant HCC cells were transfected with PLCDH-circITCH to upregulate circITCH and intervened with sorafenib, and MTT assay, flow cytometry and transwell assay were used to test the cell viability, apoptosis and migration ability, respectively. The downstream target of circITCH were explored by using bioinformatic analysis, dual luciferase reporter system and Western blot.
Results:
CircITCH was significantly down-regulated in HCC tissues and cell lines, compared with their normal counterparts. Especially, in contrast with the sorafenib-sensitive HCC cells, continuous sorafenib treatment decreased the expression levels of circITCH in the sorafenib-resistant HCC cells. Overexpression of circITCH increased sorafenib-sensitivity, promoted cell apoptosis and reduced cell migration abilities in the sorafenib-resistant HCC cells. Mechanically, circITCH elevated PTEN expression to inactivate the PI3K/Akt signals through negatively regulating miR-20b-5p in HCC, and upregulating miR-20b-5p or inhibiting PTEN abolished the enhancing effect of circITCH overexpression on sorafenib-induced cytotoxicity in sorafenib-resistant HCC cells.
Conclusion:
Taken together, this study proves that circITCH enhances sorafenib-sensitivity in sorafenib-resistant HCC cells via regulating the miR-20b-5p/PTEN/PI3K/Akt signaling cascade, which highlights the potential value of circITCH as a target for enhancing the sorafenib-sensitivity in HCC.
Insights
This study shows circular RNA ITCH (circITCH) is downregulated in hepatocellular carcinoma (HCC) and enhances sorafenib sensitivity by regulating the miR-20b-5p/PTEN/PI3K/Akt pathway, offering a potential therapeutic target for HCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sorafenib resistance is a major challenge in advanced hepatocellular carcinoma (HCC) treatment, leading to poor patient outcomes.
- Understanding the molecular mechanisms underlying sorafenib resistance is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the role of circular RNA ITCH (circITCH) in regulating sorafenib resistance in HCC.
- To elucidate the underlying molecular mechanisms by which circITCH affects sorafenib sensitivity.
Main Methods:
- Quantitative real-time PCR to assess circITCH expression in HCC tissues and cell lines.
- Cell transfection, MTT assays, flow cytometry, and Transwell assays to evaluate cell viability, apoptosis, and migration.
- Bioinformatic analysis, dual luciferase reporter assays, and Western blot to identify and validate downstream targets of circITCH.
Main Results:
- circITCH expression was significantly downregulated in HCC tissues and cells, particularly in sorafenib-resistant cells.
- Overexpression of circITCH in resistant HCC cells enhanced sorafenib sensitivity, promoted apoptosis, and reduced migration.
- circITCH was found to elevate PTEN expression by negatively regulating miR-20b-5p, thereby inactivating the PI3K/Akt signaling pathway.
Conclusions:
- circITCH enhances sorafenib sensitivity in HCC by modulating the miR-20b-5p/PTEN/PI3K/Akt signaling cascade.
- circITCH represents a promising therapeutic target for overcoming sorafenib resistance in hepatocellular carcinoma.
Related Concept Videos
Experimental RNAi
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Abnormal Proliferation

